Aidoc

Aidoc's case rests on consolidation. Rather than buying four departmental AI tools, a health system deploys aiOS once and runs radiology, cardiology, neurovascular and vascular workflows through a single enterprise platform with shared integration, care coordination and patient management. The published numbers are the ones worth quoting to a CFO: 31% faster time-to-notification for pulmonary embolism, 34% reduction in stroke door-to-puncture time (roughly 38 minutes), and 99% of eligible aortic aneurysm patients scheduled for long-term follow-up. Those are outcome metrics, not accuracy claims, which is rare in this market. Strengths start with coverage. Aidoc runs what it describes as the largest portfolio of FDA-cleared algorithms on a single platform and says its solutions touch 75% of patients in a health system, so the platform's value grows as you add specialties instead of resetting with each new vendor. Care coordination routes alerts to the right clinician rather than a generic queue, and patient management keeps incidental and surveillance findings — aortic aneurysm, VTE, IVC filters — from falling through the cracks after the initial read. Governance is a genuine differentiator: the BRIDGE Guidelines framework and the AI Strategy resources address the adoption problem that sinks most clinical AI pilots. Aidoc also reports 1,600-plus medical centers worldwide, useful social proof for a skeptical clinical committee. Weaknesses are structural. This is a hospital-scale deployment with custom configuration into existing EHR and PACS environments; the vendor's own framing is 'minimal IT lift' but the work is still yours to scope. Pricing is not published, so budgeting starts with a sales conversation rather than a calculator. Depth in any single disease area may trail a dedicated specialist vendor — if your only need is large-vessel-occlusion triage, a focused tool can be the more efficient buy. And because aiOS is proprietary and central, switching costs are high once you build departmental workflows on it. Where it fits: multi-hospital systems, academic medical centers and regional networks standardizing clinical AI across departments, especially those with a governance mandate. Where it doesn't: independent clinics, imaging centers without the IT bench to integrate, and single-department buyers who want one algorithm rather than a platform.